Pete Stavropoulos
Stock Analyst at Cantor Fitzgerald
(0)
# 4247
Out of 5,326 analysts
49
Total ratings
21.74%
Success rate
-11.00%
Average return
Main Sectors:
Top Industries:
| Name | Action | Price Target | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
VYGR Voyager Therapeutics | Reiterates: Overweight | n/a | n/a | n/a | 2 | Mar 12, 2025 | |
ARCT Arcturus Therapeutic... | Reiterates: Overweight | n/a | n/a | n/a | 6 | Mar 7, 2025 | |
PLRX Pliant Therapeutics | Reinstates: Neutral | n/a | n/a | n/a | 5 | Mar 4, 2025 | |
KALV KalVista Pharma | Reiterates: Overweight | n/a | n/a | n/a | 1 | Dec 9, 2024 | |
ALEC Alector | Reiterates: Overweight | n/a | n/a | n/a | 5 | Nov 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | n/a | n/a | n/a | 9 | Nov 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | n/a | n/a | n/a | 1 | Oct 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | 107 107 | 23.42 | 356.87% | 7 | Oct 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Overweight | n/a | n/a | n/a | 1 | Jun 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | n/a | n/a | n/a | 4 | Jun 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | 5 | 3.94 | 26.9% | 3 | Sep 19, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | 13 | 1.1 | 1081.82% | 2 | Jul 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | 15 | n/a | n/a | 2 | Jun 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | 8 | 8.53 | -6.21% | 1 | Mar 20, 2023 |